Dividend Growth Stock List: 8 Names Yielding Up To 8.3%
Wall Street analysts have one job: predict where companies' earnings are going in the coming quarter. Sounds simple enough, except said suits aren't so good at it!
CHE - Chemed Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$475.00
DETAILS
HIGH:
$475.00
LOW:
$475.00
MEDIAN:
$475.00
CONSENSUS:
$475.00
DOWNSIDE:
2.78%
Stock News
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
CINCINNATI, July 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2026, on Tuesday, July 28, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m.
Should You Hold Chemed Stock in Your Portfolio Now?
CHE's VITAS growth and Roto-Rooter improvements support its outlook, but inflation, tariffs and competitive pressures remain key risks.
AVAH or CHE: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
CINCINNATI, June 08, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired a formerly independent Roto-Rooter franchise serving 21 counties in south Texas for approximately $12.0 million. The service area includes the cities of Corpus Christi, McAllen, Laredo and Brownsville, Texas.
AVAH vs. CHE: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Aveanna Healthcare (AVAH) or Chemed (CHE). But which of these two stocks is more attractive to value investors?
Chemed Corporation (CHE) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Chemed Corporation (CHE) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2026 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2026.
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2026 annual stockholders' meeting.
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
CINCINNATI, May 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, at approximately 8:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City.
Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
CINCINNATI, May 05, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2026 Health Care Conference on Tuesday, May 12, 2026, at 3:00 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations).
CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down
Chemed stock jumps after Q1 earnings and revenues beat estimates despite margin contraction and mixed segment performance across VITAS and Roto-Rooter.
Chemed (NYSE:CHE) & LifeStance Health Group (NASDAQ:LFST) Financial Comparison
Chemed (NYSE: CHE - Get Free Report) and LifeStance Health Group (NASDAQ: LFST - Get Free Report) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability. Institutional and Insider Ownership 95.9% of Chemed
Chemed Corporation $CHE Shares Bought by Cwm LLC
Cwm LLC boosted its holdings in shares of Chemed Corporation (NYSE: CHE) by 88.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,084 shares of the company's stock after purchasing an additional 1,914 shares during the period. Cwm LLC's holdings in
Abacus FCF Advisors LLC Acquires New Holdings in Chemed Corporation $CHE
Abacus FCF Advisors LLC bought a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 13,871 shares of the company's stock, valued at approximately $5,935,000. Abacus FCF Advisors LLC owned 0.10% of Chemed at
Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript
Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript
Chemed (CHE) Beats Q1 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.65 per share, beating the Zacks Consensus Estimate of $5.17 per share. This compares to earnings of $5.63 per share a year ago.
Price Targets
Jefferies Downgrades Chemed (CHE) to Hold
$475.00
(was $453.53)
Brian Tanquilut
·
Jefferies
Chemed upgraded to Buy from Hold at Jefferies
$550.00
(was $464.00)
Jefferies
Chemed (CHE) PT Lowered to $633 at RBC Capital
$633.00
(was $534.41)
Frank Morgan
·
RBC Capital
Chemed (CHE) PT Lowered to $697 at RBC Capital
$697.00
(was $564.34)
Frank Morgan
·
RBC Capital
RBC Capital Maintains Outperform on Chemed, Raises Price Target to $592
$592.00
(was $492.25)
RBC Capital